Beta Drugs Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 9.61 | 9.61 | 9.61 | 9.61 | 8.65 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 86.64 | 67.85 | 53.80 | 46.83 | 31.95 |
| Loan funds | |||||
| Secured loans | 3.73 | 5.15 | 3.89 | 7.42 | 6.43 |
| Unsecured loans | - | - | - | - | - |
| Total | 99.98 | 82.61 | 67.30 | 63.86 | 47.02 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 59.19 | 53.54 | 43.01 | 31.67 | 19.06 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 24.41 | 19.48 | 14.99 | - | 7.29 |
| Net block | 34.77 | 34.06 | 28.01 | 31.67 | 11.77 |
| Capital work-in-progress | - | - | 1.90 | 0.08 | 15.04 |
| Investments | 6.55 | 6.54 | 6.54 | 6.12 | 1.61 |
| Net current assets | |||||
| Current assets, loans & advances | 92.72 | 70.30 | 49.78 | 44.35 | 36.23 |
| Less : current liabilities & provisions | 34.06 | 28.28 | 18.93 | 18.36 | 17.63 |
| Total net current assets | 58.66 | 42.01 | 30.85 | 26.00 | 18.60 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 99.98 | 82.61 | 67.30 | 63.86 | 47.02 |
| Notes: | |||||
| Book value of unquoted investments | 6.55 | 6.54 | 6.54 | 6.12 | 1.61 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 0.74 | 0.66 | 0.51 | 0.27 | - |
| Number of equity sharesoutstanding (Lacs) | 96.14 | 96.14 | 96.14 | 96.14 | 86.50 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis